Post-translational inhibition of cytochrome P-450 2E1 expression by chlomethiazole in Fao hepatoma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 847-852

  Simi, Anastasia ^a   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; CHLORZOXAZONE; CLOMETHIAZOLE; CYCLOHEXIMIDE; DIMETHYLNITROSAMINE DEMETHYLASE; MESSENGER RNA; NUCLEAR RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; CATALYSIS; CONFERENCE PAPER; ENZYME INHIBITION; HEPATOMA CELL; HYDROXYLATION; IMMUNOBLOTTING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTICONVULSANTS; BLOTTING, NORTHERN; CHLORMETHIAZOLE; CHLORZOXAZONE; CRICETINAE; CYCLOHEXIMIDE; CYTOCHROME P-450 CYP2E1; HUMANS; HYDROXYLATION; LIVER NEOPLASMS, EXPERIMENTAL; MICROSOMES, LIVER; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SYNTHESIS INHIBITORS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032960971     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P and Guillouzo A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715.
2. Backlund M, Johansson I, Mkrtchian S and Ingelman-Sundberg M (1997) Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells. J Biol Chem 272:31755-31763.
3. Brady JF, Ishizaki H, Fukuto JM, Lin MC, Fadel A, Gapac JM and Yang CS (1991a) Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem Res Toxicol 4:642-647.
4. Brady JF, Wang MH, Hong JY, Xiao F, Li Y, Yoo JS, Ning SM, Lee MJ, Fukuto JM, Gapac JM and Yaug CS (1991b) Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide. Toxicol Appl Pharmacol 108: 342-354.
5. Brady JF, Xiao F, Wang MH, Li Y, Ning SM, Gapac JM and Yang CS (1991c) Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in rats. Toxicol Appl Pharmacol 108:366-373.
6. Castillo T, Koop DR, Kamimura S, Triadafilopoulos G and Tsukamoto H (1992) Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation. Hepatology 16:992-996.
7. Chen Q and Cederbaum AI (1998) Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells. Mol Pharmacol 53:638-648.
8. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
9. Cornelis JE and Reiners JJJ (1996) Quantitative RT-PCR on CYP1A1 heterogeneous nuclear RNA: A surrogate for the in vitro transcription run-on assay. BioTechniques 20:470-477.
10. de Waziers I, Bouguet J, Beaune PH, Gonzalez FJ, Ketterer B and Barouki R (1992) Effects of ethanol, dexamethasone and RU 486 on expression of cytochromes P450 2B, 2E, 3A and glutathione transferase pi in a rat hepatoma cell line (Fao). Pharmacogenetics 2:12-18.
11. de Waziers I, Garlatti M, Bouguet J, Beaune PH and Barouki R (1995) Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line. Mol Pharmacol 47:474-479.
12. Ekström G and Ingelman-Sundberg M (1989) Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem. Pharmacol 38:1313-1319.
13. Eliasson E, Johansson I and Ingelman-Sundberg M (1990) Substrate-, hormone- and cAMP-regulated cytochrome P450 degradation. Proc Natl Acad Sci USA 87:3225.
14. Eliasson E and Kenna JG (1996) Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 50:573-582.
15. Fang C, Lindros KO, Badger TM, Ronis MJ and Ingelman-Sundberg M (1998) Zonated expression of cytokines in rat liver: Effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlomethiazole. Hepatology 27:1304-1310.
16. French SW, Zhanggouillon ZQ and Ingelmansundberg M (1998) The role of Cyp2e1 induction by ethanol in the pathogenesis of alcoholic liver disease as determined by inhibitors of Cyp2e1 transcription and posttranslation modulating factors. Alcohol Clin Exp Res 22:738-739.
17. Gebhardt AC, Lucas D, Menez JF and Seitz HK (1997) Chlomethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology 26:957-961.
18. Girre C, Lucas D, Hispard E, Menez C, Dally S and Menez JF (1994) Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 47:1503-1508.
19. Glatt MM, George HR and Frisch EP (1966) Evaluation of chlomethiazole in treatment for alcohol withdrawal syndrome: Results of a controlled trial. Acta Psychiatr Scand Suppl 192:121-137.
20. Haslam MT (1976) Use of chlomethiazole in anxiety states: A double-bind crossover trial. Pharmatherapeutica 1:65-70.
21. Hu Y, Ingelman-Sundberg M and Lindros KO (1995) Induction mechanisms of cytochrome P450 2E1 in liver: Interplay between ethanol treatment and starvation. Biochem Pharmacol 50:155-161.
22. Hu Y, Mishin V, Johansson I, von Bahr C, Cross A, Ronis MJ, Badger TM and Ingelman-Sundberg M (1994) Chlomethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver. J Pharmacol Exp Ther 269:1286-1291.
23. Ingelman-Sundberg M, Johansson I, Yin H, Terelius Y, Eliasson E, Clot P and Albano E (1993) Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 10:447-452.
24. Ishizaki H, Brady JF, Ning SM and Yang CS (1990) Effect of phenethyl isothiocyanate on microsomal N-nitrosodimethylamine metabolism and other monooxygenase activities. Xenobiotica 20:255-264.
25. Jeong KS, Lee IJ, Roberts BJ, Soh Y, Yoo JK, Lee JW and Song BJ (1996) Transcriptional inhibition of cytochrome P4502E1 by a synthetic compound, YH439. Arch Biochem Biophys 326:137-144.
26. Johansson I, Ekström G, Scholte B, Puzycki D, Jörnvall H and Ingelman-Sundberg M (1988) Ethanol-, fasting-, and acetone-inducible cytochromes P-450 in rat liver: Regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies. Biochemistry 27:1925-1934.
27. Johansson I and Ingelman-Sundberg M (1988) Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res 48:5387-5390.
28. Johansson I, Lindros KO, Eriksson H and Ingelman-Sundberg M (1990) Transcriptional control of CYP2E1 in the perivenous liver region and during starvation. Biochem Biophys Res Commun 173:331-338.
29. Koop DR (1990) Inhibition of ethanol-inducible cytochrome P450IIE1 by 3-amino-1,2,4-triazole. Chem Res Toxicol 3:377-383.
30. Kwak MK, Kim SG, Kwak JY, Novak RF and Kim ND (1994) Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethylsulfide in rats. Biochem Pharmacol 47:531-539.
31. McGrath SD (1975) A controlled trial of chlomethiazole and chlordiazepoxide in the treatment of the acute withdrawal phaae of alcoholism. Br J Addict Alcohol Other Drugs 70:81-90.
32. Morgan MY (1995) The management of alcohol withdrawal using chlomethiazole. Alcohol Alcohol 30:771-774.
33. Morimoto M, Hagbjork AL, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, Albano E and French SW (1993) Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 10:459-464.
34. Morimoto M, Hagbjork AL, Wan YJ, Fu PC, Clot P, Albano E, Ingelman-Sundberg M and French SW (1995) Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 21:1610-1617.
35. Neve E, Eliasson E, Pronzato MA, Albano E, Marinari U and Ingelman-Sundberg M (1996) Enzyme-specific transport of rat liver cytochrome P450 to the Golgi apparatus. Arch Biochem Biophys 333:459-465.
36. Ronis MJJ, Lindros KO and Ingelman-Sundberg M (1996) The CYP2E subfamily, in Cytochromes P450: Metabolic and Toxicological Aspects (Ioannides C ed) pp 211-239, CRC Press, New York.
37. Schmalix WA, Barrenscheen M, Landsiedel R, Janzowski C, Eisenbrand G, Gonzalez F, Eliasson E, Ingelman-Sundberg M, Perchermeier M, Greim H and Doehmer J (1995) Stable expression of human cytochrome P450 2E1 in V79 Chinese hamster cells. Eur J Pharmacol 293:123-131.
38. Song BJ, Gelboin HV, Park SS, Yang CS and Gonzalez FJ (1986) Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme [published erratum appears in J Biol Chem (1987) 25:8940]. J Biol Chem 261: 16689-16697.
39. Song BJ, Matsunaga T, Hardwick JP, Park SS, Veech RL, Yang CS, Gelboin HV and Gonzalez FJ (1987) Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol Endocrinol 1:542-547.
40. Struhl K (1993) Analysis of RNA by Northern and slot blot hytonidization, in Current Protocols in Molecular Biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K eds) pp 4.9.1-4.9.14, John Wiley & Sons, New York.
41. Tindberg N and Ingelman-Sundberg M (1996) Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system. J Neurochem 67:2066-2073.
42. Towbin J, Staehelin T and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
43. Ueno T and Gonzalez FJ (1990) Complete sequence of the rat CYP2A3 gene specifically transcribed in lung. Nucleic Acids Res 18:4623-4624.
44. Ueshima Y, Matsuda Y, Wang BY, Takase S and Takada A (1993) Ethanol and acetaldehyde metabolism in cultured rat hepatocytes. Alcohol Alcohol Suppl 1:A3-A10.
45. Zhukov A and Ingelman-Sundberg M (1997) Selective fast degradation of cytochrome P-450 2E1 in serum-deprived hepatoma cells by a mechanism sensitive to inhibitors of vesicular transport. Eur J Biochem 247:37-43.